j.hartmann
Submits third-party assay reports on material purchased directly. Based in Linz.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.15%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042789 | CJC-1295 (no DAC) | GGPeps | GGPE-2507-D9435 | Janoshik | 2025-Q4 | 98.03 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004752 | MGF | TFC | TFC-2408-M9471 | Nordanalyt | 2024-Q4 | 99.87 | 3.25 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004545 | Semaglutide | HYB | HYB-2407-V2291 | Medutest | 2024-Q4 | 98.27 | 4.06 | 104.4 | Buyer-sourced | 1 | FAIL |
| AX-2024-005511 | Tirzepatide | BCH | BCH-2404-N7401 | Nordanalyt | 2024-Q3 | 97.36 | 3.24 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004803 | Retatrutide | Homopeptide | HOMO-2405-B1185 | Janoshik | 2024-Q3 | 98.54 | 5.89 | 103.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005282 | Tirzepatide | SSA | SSA-2312-V8264 | VendorInvestigate | 2024-Q2 | 97.88 | 5.16 | 94.0 | Buyer-sourced | 0 | PASS |